Results 141 to 150 of about 5,004 (196)

[Responses and resistance in the fight against smallpox, Chile, eighteenth to twentieth centuries]. [PDF]

Hist Cienc Saude Manguinhos
Caffarena P.
europepmc   +1 more source

Challenges and Opportunities for Adult Vaccine Coverage: Insights for Healthcare Professionals Focusing on Herpes Zoster in Mexico. [PDF]

Vaccines (Basel)
Cervantes-Apolinar MY, Guzman-Holst A, Mascareñas De Los Santos A, Macías Hernández AE, Cabrera Á, Lara-Solares A, Abud Mendoza C, Motola Kuba D, Flores Díaz DF, Salgado Gomez F, Castro-Narro GE, Nieto J, Mata-Marín JA, Barba Gómez JF, Tinoco JC, Calleja Castillo JM, Contreras Serratos MM, Castellanos Ramos N, Rosas Carrasco O, Ricaño R, Huerta García GC.   +20 more
europepmc   +1 more source

Mujer junto a un camión de Salubridad y Asistencia

, 1940
Casasola (photographer)
core  

A U.S. Pharmacopeia (USP) overview of Pan American botanicals used in dietary supplements and herbal medicines. [PDF]

Front Pharmacol
Upton R, Agudelo I, Cabrera Y, Caceres A, Calderón A, Calzada F, Camacho R, da Costa F, Dobrecky C, Enciso R, Escobar M, Fakhary M, Fletcher E, Gao Q, Lock O, Mata R, Parada M, Perera W, Pombo LM, Reich E, Sanchez E, Simirgiotis MJ, Sood C, Amiguet VT, Villar M, Ghelman R, Schveitzer MC, Portella CFS, Wolffenbüttel A, Ruppelt B, Frickmann FS, Gavillan-Suarez J, Allen K, Alvarado LD, Sarma N, Marles R, Monagas M, Navarro-Hoyos M.   +37 more
europepmc   +1 more source

Funcionarios y militares frente al Departamento de Salubridad Públca

, 1920
Casasola (photographer)
core  

[PROGRAM OF THE ESCUELA DE SALUBRIDAD Y ASISTENCIA, 1965].

Salud publica de Mexico, 1996
M, SALAZARMALLEN, D, GONZALEZBARRANCO
openaire   +1 more source

[Brief history of laboratory-based epidemiological surveillance in the Mexican Institute for Social Security]. [PDF]

Rev Med Inst Mex Seguro Soc
Santacruz-Tinoco CE, Alvarado-Yaah JE, Anguiano-Hernández YM, Martínez-Miguel B, Cabrera-Gaytán DA, Chávez-Navarro L.   +5 more
europepmc   +1 more source

Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico. [PDF]

PLoS One
Diaz Martinez JP, Aubry de Maraumont T, Natty Sánchez E, Camacho Cordero LM, Yeh E.   +4 more
europepmc   +1 more source